BFC
GILD icon

Bedel Financial Consulting’s Gilead Sciences GILD Stock Holding History

Bedel Financial Consulting’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
1,607
+1
+0.1% +$132 0.02% 304
2026
Q1 		$224K Buy
+1,606
New +$225K 0.03% 279
2022
Q2 		– Sell
-1,789
Closed -$106K – 449
2022
Q1 		$106K Buy
1,789
+141
+9% +$9.01K 0.03% 270
2021
Q4 		$120K Buy
1,648
+1
+0.1% +$69 0.04% 250
2021
Q3 		$115K Hold
1,647
– – 0.04% 250
2021
Q2 		$113K Sell
1,647
-573
-26% -$38.3K 0.04% 247
2021
Q1 		$143K Buy
2,220
+1,897
+587% +$122K 0.06% 211
2020
Q4 		$19K Sell
323
-100
-24% -$6.03K 0.01% 457
2020
Q3 		$27K Buy
423
+100
+31% +$6.93K 0.01% 387
2020
Q2 		$25K Sell
323
-6
-2% -$460 0.01% 372
2020
Q1 		$25K Buy
329
+9
+3% +$622 0.02% 356
2019
Q4 		$21K Hold
320
– – 0.01% 404
2019
Q3 		$20K Hold
320
– – 0.01% 393
2019
Q2 		$22K Hold
320
– – 0.01% 379
2019
Q1 		$21K Hold
320
– – 0.01% 382
2018
Q4 		$20K Sell
320
-150
-32% -$10.5K 0.01% 360
2018
Q3 		$35K Buy
470
+250
+114% +$18.9K 0.02% 312
2018
Q2 		$16K Buy
220
+1
+0.5% +$71 0.01% 408
2018
Q1 		$17K Buy
+219
New +$17.4K 0.01% 403

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bedel Financial Consulting's GILD Position: Q2 2026 in Review

Bedel Financial Consulting increased its Gilead Sciences (GILD) stake by 0.06% in Q2 2026, buying an estimated $132 and bringing the position to 1,607 shares worth $203K. The position accounts for 0.02% of the portfolio, ranked #304.

Bedel Financial Consulting first reported a position in GILD in Q1 2018 and has held it in 19 quarters since. The position peaked at $224K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bedel Financial Consulting held 1,607 shares of Gilead Sciences worth $203K as of Q2 2026.
  • Bedel Financial Consulting bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up 0.02% of Bedel Financial Consulting's portfolio in Q2 2026, its #304 holding.
  • Bedel Financial Consulting first reported a position in Gilead Sciences in Q1 2018 and has held it in 19 quarters since.
  • Bedel Financial Consulting's Gilead Sciences position peaked at $224K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bedel Financial Consulting's 13F filing for Q2 2026, filed 29 Jul 2026.